145 related articles for article (PubMed ID: 22796372)
1. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer.
Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU
Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372
[TBL] [Abstract][Full Text] [Related]
2. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer.
Sheng SL; Huang G; Yu B; Qin WX
Clin Chem; 2009 Sep; 55(9):1656-64. PubMed ID: 19628661
[TBL] [Abstract][Full Text] [Related]
4. Serum Dickkopf-1 acts as a new biomarker in human breast cancer.
Liu JT; Guo WB; Sun JY
Minerva Med; 2017 Aug; 108(4):334-340. PubMed ID: 28248066
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.
Hong SA; Yoo SH; Lee HH; Sun S; Won HS; Kim O; Ko YH
BMC Cancer; 2018 May; 18(1):506. PubMed ID: 29720122
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
7. Assessing the diagnostic value of serum Dickkopf-related protein 1 levels in cancer detection: a case-control study and meta-analysis.
Jiang XT; Ma YY; Guo K; Xia YJ; Wang HJ; Li L; He XJ; Huang DS; Tao HQ
Asian Pac J Cancer Prev; 2014; 15(21):9077-83. PubMed ID: 25422182
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma.
Tung EK; Mak CK; Fatima S; Lo RC; Zhao H; Zhang C; Dai H; Poon RT; Yuen MF; Lai CL; Li JJ; Luk JM; Ng IO
Liver Int; 2011 Nov; 31(10):1494-504. PubMed ID: 21955977
[TBL] [Abstract][Full Text] [Related]
9. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels.
Granchi D; Corrias MV; Garaventa A; Baglìo SR; Cangemi G; Carlini B; Paolucci P; Giunti A; Baldini N
Bone; 2011 Jan; 48(1):152-9. PubMed ID: 20603237
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer.
Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS
Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Dickkopf-1 in Gastric Cancer Survival: A Meta-Analysis.
Liu QR; Li YF; Deng ZQ; Cao JQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):170-5. PubMed ID: 27023747
[TBL] [Abstract][Full Text] [Related]
13. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
14. The use of tumor markers as predictors of prognosis in gastric cancer.
Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
[TBL] [Abstract][Full Text] [Related]
15. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
16. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer.
Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC
Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530
[TBL] [Abstract][Full Text] [Related]
17. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
18. Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors.
Caldwell C; Rottman JB; Paces W; Bueche E; Reitsma S; Gibb J; Adisetiyo V; Haas MS; Heath H; Newman W; Baum J; Gianani R; Kagey MH
Sci Rep; 2021 May; 11(1):9920. PubMed ID: 33972574
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
[TBL] [Abstract][Full Text] [Related]
20. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
